The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Mizutani Foundation for Glycoscience is a non-profit organization established on October 1, 1992 with funds donated by the late Mr. Masakane Mizutani, former Emeritus Chairman of Seikagaku Corporation, Tokyo, Japan. The objective of the Foundation is to promote world-wide progress in glycoscience. In accordance with this objective, the Foundation provides research grants to outstanding proposals for basic and applied studies on glycoconjugate in the fields of organic chemistry, biochemistry, biophysics, molecular biology, cellular biology and medical sciences.
Deadline: Sep. 1, 2023
The applicant (principal investigator) must 1) have a doctor's degree or its equivalent in a field relevant to the proposed project, 2) have a documented capability of performing independent studies, 3) be a member of a scientific institution (applicant organization) where he or she can carry out the proposed study and 4) have not been awarded the Mizutani grant between 2019 and 2023(the grantee may re-apply after a period of five years.)
In principle, a grant will be approved for one year, from April 1, 2024 to March 31, 2025. However, if desired, the period can be extended another year without any additional grant after obtaining the approval of the Foundation. The maximum amount of a grant is 7,000,000 yen (approximately US$52,000 as of March, 2023.) The total budget for the grants is 70,000,000 yen per annum. The grant may be used for various items necessary for the proposed study, but not for the salaries of the principal or collaborative investigators. The proposed study may be a part of a large project, including an international collaboration. However, only a single investigator is considered to be the principal investigator. As much as 10% of the total grant may be used for indirect costs (overheads.)